Articles for author: Ron Finklestien

March 28, 2024

Ron Finklestien

Lockheed Martin Emerges Victorious with $440M Contract for F-35 Program

Lockheed Martin Corporation LMT has recently clinched a commendable modification contract for its esteemed F-35 aircraft. The prestigious award has been bestowed upon them by the esteemed Naval Air Systems Command, Patuxent River, MD. A Maverick Deal The contract, valued at a staggering $439.9 million, is projected to conclude by December 2029. Under the terms of this covetable deal, Lockheed will offer top-notch logistics and support for the F-35A, F-35B, and F-35C aircraft. This agreement encompasses the provision of support equipment, pilot flight gear, post-ejection survival training material, along with ancillary administrative, contract management, planning, and readiness reviews. It also

March 28, 2024

Ron Finklestien

Decoding Nvidia’s Bold Venture: The Arm Holdings AI Investment Enigma

Nvidia (NASDAQ: NVDA) has undoubtedly been the star player in the AI game, boasting an impressive track record of innovation. In a recent move that turned heads on Wall Street, Nvidia unveiled its initial 13F filing with the SEC, showcasing a foray into multiple AI stocks that caught the attention of astute investors. This filing was triggered by the cumulative value of these investments crossing the $100 million mark for the quarter ended Dec. 31, marking a significant milestone for the tech giant. With Nvidia’s renowned expertise in the realm of AI, it’s only natural that market watchers are eager

March 28, 2024

Ron Finklestien

Record U.S. Soybean Crush in February Indicates Growing Demand Record U.S. Soybean Crush in February Indicates Growing Demand

By Karl Plume February Crush Performance CHICAGO, March 28 (Reuters) – The U.S. soybean crush likely increased in February to 5.893 million short tons, or 196.4 million bushels, following weather-reduced operations the previous month, according to analysts surveyed by Reuters ahead of a monthly U.S. Department of Agriculture report. The soybean processing industry, like a well-oiled machine, is showing resilience and strength as it powered through challenges. Historical Perspective If the estimate, gathered from eight analysts, is realized, it would be up 0.8% from the 194.8 million bushels crushed in January and up 11.0% from the February 2023 crush of

March 28, 2024

Ron Finklestien

Revolutionizing Healthcare: 3 Companies with Potential Growth by Leaps and Bounds

Harnessing the Power of Disruptive Innovation in Healthcare As the world of healthcare undergoes a rapid evolution, investors are eyeing disruptive businesses that have the power to transform the industry and deliver exceptional returns. These companies are redefining the boundaries of healthcare delivery, making it more than just a service but an experience. A Closer Look at Hims & Hers (HIMS) Hims & Hers (NYSE:HIMS) has witnessed a significant surge in subscribers, reflecting the increasing demand for accessible and personalized healthcare options. With 1.5 million subscribers in 2023, marking a 48% year-over-year increase, the company’s strategies in attracting and retaining

March 28, 2024

Ron Finklestien

Biotech Breakthroughs: PRAX & VKTX Thrive on New Findings, MRNA & REGN Forge Ahead

The Week’s Key Highlights The biotech landscape was abuzz with revelations and advancements this week, showcasing the transformative power of innovation in the sector. Among the standout performers were Praxis Precision Medicines, Inc. (PRAX) and Viking Therapeutics, Inc. (VKTX), each making remarkable strides based on study outcomes. Regeneron’s Regulatory Roadblock Regeneron Pharmaceuticals, Inc. (REGN) faced a challenging moment as the FDA handed out Complete Response Letters (CRLs) for its biologics license application (BLA) pertaining to odronextamab, targeting relapsed/refractory (R/R) follicular lymphoma (FL) and R/R diffuse large B-cell lymphoma (DLBCL). The primary concern highlighted by the CRLs was the enrollment status

March 28, 2024

Ron Finklestien

Unpacking KB HOME Stock’s Surge Above Analyst Predictions

Analysts: Up Close and Personal As the dust settles on the trading floor, KB HOME (Symbol: KBH) emerges victorious, surpassing the average analyst’s 12-month target price of $68.19 to hit $69.56 per share. This pivotal moment beckons analysts to reevaluate their stance — do they dial down on valuation or set sail for loftier price targets? The stock’s delightful climb may trigger a revision in figures. Amidst this fervor, underlying business dynamics play a hand in these upward strides, beckoning analysts to either heighten their target prices or exercise caution as the stock scales new heights. The Varied Symphony of

March 28, 2024

Ron Finklestien

GBP Consolidates Amid Concerns Over Economic Growth And Wage Trends

The Pulse of the GBP Amid Economic Growth and Wages The GBP/USD Pair in a Consolidation Phase The GBP/USD pair remains steady around the 1.2631 mark, reflecting the market’s current consolidation phase. Recent reports have shed light on a concerning deceleration in the growth plans of British businesses regarding workforce expansion and wage increments. This slowdown is sparking worries about the future economic landscape and potential inflationary trends. Insights from the Lloyds Bank Business Barometer The latest report from the Lloyds Bank Business Barometer reveals a notable downturn in companies’ hiring outlook. The gap between firms looking to recruit and

March 28, 2024

Ron Finklestien

Amazon’s Strategic Real Estate Plan to Reduce Vacancy Rate and Enhance Workspace Efficiency Amazon Charts Course to Trim Vacancy and Boost Office Efficiency

Amazon.Com Inc AMZN is undertaking a bold strategy to pare down $1.3 billion in expenses by swiftly reducing its office footprint and exiting leases ahead of schedule. In a bid to streamline costs and optimize resources, the e-commerce juggernaut is poised to revamp the utilization of its corporate space, placing a significant emphasis on tackling underutilized areas. Insider information and a confidential document validate this cost-cutting venture, as per a report by Commercial Observer. Additionally: Amazon spokesperson Brad Glasser stressed that real estate choices are crafted to promote collaboration, adapt to space requirements, and rectify any excess capacity issues. He

March 28, 2024

Ron Finklestien

Investing Perseverance: Weathering Storms in the Oil & Gas Industry

Challenges Abound Amidst Stability Although the midstream energy business is generally shielded from oil and gas price fluctuations, the Oil and Gas – Pipeline MLP industry still faces uncertainties. The conservative capital spending by upstream players may impede production volume growth, impacting the demand for midstream assets. Amidst this backdrop, companies like Enterprise Products Partners LP EPD, Energy Transfer LP ET, and Plains All American Pipeline LP PAA remain at the forefront. Indispensable Industry Insights The Zacks Oil and Gas – Pipeline MLP sector encompasses master limited partnerships engaged in transporting oil, natural gas, and more across North America. With

March 28, 2024

Ron Finklestien

Consolidated Edison Inc: Analyst Target Price Surpassed

Reaching New Heights Traders witnessed Consolidated Edison Inc (Symbol: ED) shares soaring above the average analyst 12-month target price of $87.57, trading at $90.05/share. Once a stock hits this milestone, analysts face a crossroads—lower the valuation or revise the target upward in light of positive business developments driving the stock price. This intriguing tug-of-war often hinges on the trajectory of the company’s performance. Should the target price be adjusted upward as an endorsement of the company’s promising outlook? A Diverse Analyst Landscape Within the Zacks coverage universe, 14 varying analyst targets contribute to the aforementioned average for Consolidated Edison Inc.